Honestly nothing has really changed from my original Marine Biotech thread - the analysis and trade thesis still stands, its merely being fufilled and coming to fruition. Still up to management to execute on paper and get that $$$ inked over the next quarter to see if I will stay longer. Ignore the price, lets see if they can sign another $2-3M in contracts this quarter.
4c fair value ($30M), 8c short term target ($60M), page-1230
Add NZS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.334M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| NZS (ASX) Chart |
Day chart unavailable